首页> 外文期刊>BMC Medical Informatics and Decision Making >The tidal waves of connected health devices with healthcare applications: consequences on privacy and care management in European healthcare systems
【24h】

The tidal waves of connected health devices with healthcare applications: consequences on privacy and care management in European healthcare systems

机译:连接保健设备与保健应用程序的浪潮:对欧洲保健系统中隐私和保健管理的影响

获取原文
           

摘要

Background The market for Connected Health Devices (CHD) with healthcare applications is growing fast and should be worth several billion euros in turnover in the coming years. Their development will completely transform the organisation of our healthcare system, profoundly change the way patients are managed and revolutionizes disease prevention. Main body The CHD with healthcare applications is a tidal wave that has societal impact calling into question the privacy of patients’ personal and healthcare information and its protection in secure systems. Rather than trying to stop the use of CHD, we must channel the wave by clearly examining the advantages versus the risks and threats to the patients, and find counter-measures for implementation. The main difficulty is channeling the wave in a way that is acceptable to CHD developers who otherwise will bypass the rules, even if they can be sued for it. Therefore, it appears necessary to implement guidelines that can be used by all developers, defining the minimum requirement for assuring the security of patient privacy and healthcare management. Conclusion In European Healthcare Systems, there is an imperative need for establishing security guidelines that CHD producers could use to ensure compliance, so that patient privacy and healthcare management is safeguarded. The aim would be to implement the guidelines a posteriori rather than a priori control so as not to hamper innovation.
机译:背景技术带有医疗保健应用的互联式健康设备(CHD)市场正在快速增长,未来几年的营业额将达到数十亿欧元。他们的发展将完全改变我们的医疗保健系统的组织,深刻改变患者的治疗方式,并彻底改变疾病预防。主体带有医疗保健应用的冠心病是一种潮流,具有社会影响力,这使人们怀疑患者的个人和医疗保健信息的隐私及其在安全系统中的保护。与其试图停止使用冠心病,不如通过明确检查其优点与对患者的风险和威胁之间的关系,并找到实施对策的渠道。主要的困难是如何以一定的方式引导浪潮,使CHD开发人员可以接受,否则他们将绕过规则,即使可以起诉该规则。因此,似乎有必要实施可供所有开发人员使用的指南,以定义确保患者隐私和医疗保健管理安全的最低要求。结论在欧洲医疗保健系统中,迫切需要建立安全指南,CHD生产者可以使用该指南来确保合规性,从而保护患者隐私和医疗保健管理。目的是实施后验准则,而不是先验控制,以免妨碍创新。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号